Accelerate Diagnostics Inc

NASDAQ:AXDX 4:00:00 PM EDT

1.47

0.00 (0.00%)

6:52:48 PM EDT: $1.52 +0.05 (+3.40%)

Market Cap (Intraday)	34.81M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$3 Million
Adjusted EPS	-$0.47

See more estimates

10-Day MA	$1.54
50-Day MA	$1.51
200-Day MA	$1.63

See more pivots

Accelerate Diagnostics Inc Stock, NASDAQ:AXDX

3950 South Country Club Road, Suite 470, Tucson, Arizona 85714

United States of America

Phone: +1.520.365.3100

Number of Employees: 134

http://acceleratediagnostics.com

Description

Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.